Publication:
Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand (PharmacoEconomics, (2019), 37, 2, (267-278), 10.1007/s40273-018-0736-0)

Simple item page
dc.contributor.authorBunchai Chongmelaxmeen_US
dc.contributor.authorPochamana Phisalprapaen_US
dc.contributor.authorRatree Manthaisongen_US
dc.contributor.authorPiyameth Dilokthornsakulen_US
dc.contributor.authorNathorn Chaiyakunapruken_US
dc.contributor.otherNaresuan Universityen_US
dc.contributor.otherMonash University Malaysiaen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.contributor.otherMahasarakham Universityen_US
dc.contributor.otherUniversity of Wisconsinen_US
dc.date.accessioned2020-01-27T10:06:12Z
dc.date.available2020-01-27T10:06:12Z
dc.date.issued2019-02-13en_US
dc.description.abstract© 2018, Springer Nature Switzerland AG. Weight Reduction is Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.en_US
dc.identifier.citationPharmacoEconomics. Vol.37, No.2 (2019), 291en_US
dc.identifier.doi10.1007/s40273-018-0754-yen_US
dc.identifier.issn11792027en_US
dc.identifier.issn11707690en_US
dc.identifier.other2-s2.0-85060121046en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/51869
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85060121046&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleCorrection to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand (PharmacoEconomics, (2019), 37, 2, (267-278), 10.1007/s40273-018-0736-0)en_US
dc.typeErratumen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85060121046&origin=inwarden_US

Files

Collections

Scopus 2019